Validated ion pair liquid chromatography/fluorescence detection method for assessing the variability of the loratadine metabolism occurring in bioequivalence studies
- 14 May 2007
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 21 (10) , 1023-1029
Abstract
Inter‐ and intra‐individual variability of the loratadine (LOR) metabolism in Caucasian subjects was assessed during a bioequivalence study for two pharmaceutical formulations (solid oral dosage forms) containing 10 mg of the active substance. The analytical data were obtained by applying a reliable, low‐cost and sensitive ion pair liquid chromatography/fluorescence (IPLC/FLD) method for determination of both loratadine and descarboethoxyloratadine (DCL) in human plasma samples. The sample preparation procedure is based on liquid–liquid extraction of the target analytes from alkalinized plasma using diethyl‐ether. The separation of the analytes and 8‐chloroazatadine as internal standard (IS) was achieved through an isocratic ion pair (IP) elution on a Purospher® STAR RP‐18 column. The mobile phase containing sodium dodecyl sulfate (SDS) as ion pairing agent was pumped at a flow rate of 1 mL/min. Fluorescence detection (FLD) was achieved at 280 nm (excitation) and 440 nm (emission) wavelengths. The increased sensitivity of the method is also based on a large sample injected volume (250 µL). Linear response was found over the 0.5–20 ng/mL concentration interval for both target compounds. Low limits of quantification (LLOQ) around 0.3 ng/mL were found for LOR and DCL. Method validation is presented. Copyright © 2007 John Wiley & Sons, Ltd.Keywords
This publication has 12 references indexed in Scilit:
- A sensitive LC/MS/MS method using silica column and aqueous–organic mobile phase for the analysis of loratadine and descarboethoxy-loratadine in human plasmaJournal of Pharmaceutical and Biomedical Analysis, 2003
- Desloratadine: A new, nonsedating, oral antihistamineJournal of Allergy and Clinical Immunology, 2001
- Sensitive liquid chromatography–tandem mass spectrometry method for the determination of loratadine and its major active metabolite descarboethoxyloratadine in human plasmaJournal of Chromatography A, 2001
- Second-generation antihistamines: The risk of ventricular arrhythmiasClinical Therapeutics, 1999
- Sensitive gas—liquid chromatographic method for the determination of loratadine and its major active metabolite, descarboethoxyloratadine, in human plasma using a nitrogen—phosphorus detectorJournal of Chromatography B: Biomedical Sciences and Applications, 1994
- Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populationsEuropean Journal of Clinical Pharmacology, 1990
- Pharmacokinetics and Dose Proportionality of LoratadineThe Journal of Clinical Pharmacology, 1987
- Selective displacement of [3H]mepyramine from peripheral vs. central nervous system receptors by loratadine, a non-sedating antihistamineEuropean Journal of Pharmacology, 1986
- Pharmacologic evaluation of loratadine (SCH 29851), chlorpheniramine and placeboEuropean Journal of Clinical Pharmacology, 1986
- Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populationsClinical Pharmacology & Therapeutics, 1985